Skip to main content

Glatiramer Dosage

Medically reviewed by Last updated on Sep 23, 2021.

Applies to the following strengths: 20 mg; 20 mg/mL; 40 mg/mL

Usual Adult Dose for Multiple Sclerosis

20 mg subcutaneously once a day or 40 mg subcutaneously 3 times a week

-For the 3 times a week dosage regimen, each dose must be separated by at least 48 hours.
-Length of treatment should be individualized.

Approved indication: For the treatment of patients with relapsing forms of multiple sclerosis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

-Because this drug can modify immune response, it could possibly interfere with useful immune function.
-Injection sites should be rotated.
-This drug should only be administered subcutaneously, not IV or IM.
-The initiation of treatment should be supervised by a neurologist or a physician experienced in the treatment of MS.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.